APA (7th ed.) Citation

Matos, L., Vilela, R., Rocha, M., Santos, J. I., Coutinho, M. F., Gaspar, P., . . . Alves, S. (2021). Development of an antisense oligonucleotide-mediated exon skipping therapeutic strategy for Mucolipidosis II: Validation at RNA level.

Chicago Style (17th ed.) Citation

Matos, Liliana, Regina Vilela, Melissa Rocha, Juliana Inês Santos, Maria Francisca Coutinho, Paulo Gaspar, Maria João Prata, and Sandra Alves. Development of an Antisense Oligonucleotide-mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level. 2021.

MLA (8th ed.) Citation

Matos, Liliana, et al. Development of an Antisense Oligonucleotide-mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level. 2021.